TRXB — TRex Bio Balance Sheet
0.000.00%
Last trade - 00:00- $371.07m
- $240.62m
Annual balance sheet for TRex Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 65.3 | 67.7 |
| Prepaid Expenses | ||
| Total Current Assets | 66.8 | 71.4 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 1.29 | 1.16 |
| Other Long Term Assets | ||
| Total Assets | 68.1 | 73.1 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 7.54 | 4.99 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 8.79 | 6.24 |
| Redeemable Preferred Stock | ||
| Non Redeemable Preferred Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Unrealized Gain / Loss | ||
| Total Equity | 59.3 | 66.9 |
| Total Liabilities & Shareholders' Equity | 68.1 | 73.1 |
| Total Common Shares Outstanding |